Biotech | July 16, 2022
Enveric Biosciences advances drug development for mental health indications
Advancing to IND-enabling studies with multiple drug candidates
Advancing to IND-enabling studies with multiple drug candidates
Syngene's collaboration with Zoetis started in 2011
H.C. Wainwright & Co. acted as the exclusive placement agent for the offering.
Novavax' vaccine is the first protein-based COVID-19 vaccine authorized in the U.S.
This acquisition is in line with Cipla's strategic imperative to augment the company's wellness portfolio for bringing about a shift from an illness to a wellness mindset.
The expansion at CDMO facility in South Haven, will bring a new 4,000-gallon multi-use reactor train consisting of glass lined and stainless-steel materials of construction
An algorithm based testing for Fatty Liver Disease
EVERSANA and Compai Pharma will provide medical and commercial resources to healthcare partners
Plant is part of the company's CAD $30 million capital investment in the site
Granite Bio's lead candidate is a novel monoclonal antibody for treatment of autoimmune and certain cancer indications. B
Subscribe To Our Newsletter & Stay Updated
